Written by: Heather Helmendach, Legal Assistant
Law Offices of Thomas J. Lamb, P.A.
At the Law Offices of Thomas J. Lamb, we are committed to providing up-to-date information on matters pertaining to drug injury law. Over the course of 2017, we have reviewed countless medical studies and journals, and reported the significant medical, legal, and regulatory developments through our two blogs.
Attorney Tom Lamb's blog, Drug Injury Watch, consists of articles related to serious side effects of prescription drugs, and major developments in some of the current drug litigations.
My blog, Drug Safety Developments, reports and elaborates on the information contained in medical and legal news concerning the safety of brand-name prescription drugs.
Below, I have provided an index of the articles published on the Drug Injury Watch blog in 2017. These articles are organized categorically, and listed in the following section. Click on the categories below to jump to that section of the page, then click on the title of the article to view it in full at its source.
Categories:
- SGLT-2 Inhibitors Diabetes Drugs
- Hepatitis C Treatment Drugs
- Anticoagulants / Bloodthinners
- Breast Implants
- Osteoporosis Treatment Drugs
- Erectile Dysfunction (ED) Drugs
- Heartburn / Acid Reflux Drugs
- Multiple Sclerosis (MS) Treatment Drugs
- DPP-4 Inhibitors Diabetes Drugs
- Miscellaneous
SGLT-2 Inhibitors Diabetes Drugs:
- Jardiance – Amputations Drug Safety Issue Remains Uncertain Due To Admitted "inherent limitations of… post hoc analyses" (11/28/17)
- Medical Researchers Continue To Study Bladder Cancer As A Possible Side Effect Of Jardiance (11/7/17)
- Invokana – Amputations Of Lower Limbs: A Drug Side Effect Which Needs Further Explanation As Regards "How" And "Why" (10/24/17)
- A "Dear Doctor" Letter For Invokana Amputations Side Effect Was Sent September 2017 By Janssen In Canada (9/7/17)
- Analysis Of FDA Adverse Event Reports Describes Extent And Nature of Invokamet / Invokana – Amputation Side Effect (8/10/17)
- Invokana – Amputation Side Effect Gets "Black-Box Warning" On Revised Drug Label Issued In July 2017 (7/27/17)
- Jardiance, Invokana, Farxiga, And The Other SGLT2 Inhibitors Might Double The Risk Of Diabetic Ketoacidosis (DKA) (6/8/17)
- Farxiga MDL Created In April 2017; Assigned to Federal Court Judge Lorna Schofield In New York (5/12/17)
- Federal Court Invokana MDL: Judge Martinotti Is Presiding Over These Drug Injury Lawsuits In New Jersey (3/14/17)
- Pending Motion Requests Multidistrict Litigation (MDL) For Farxiga And Xigduo XR Lawsuits Filed In Federal Court (3/8/17)
- Diabetes Medicine Invokana Gets New Warning About Lower Limb Amputation Added To Drug Package Insert In Canada (1/2/17)
Hepatitis C Treatment Drugs:
- Health Canada: There Is No Apparent Link Between Sovaldi Or Harvoni With Liver Cancer Recurrence As Of April 2017 (6/1/17)
- Harvoni / Sovaldi: Spring 2017 Update On Issue Of Liver Cancer Recurrence After Using Direct-Acting Antiviral "Hep-C" Drugs (4/27/17)
- February 2017 Label Changes For Sovaldi, Harvoni, And Other DAA Hepatitis C Drugs Are Made So As To Add A "Black-Box" Warning (2/16/17)
- New Safety Issue: Direct-Acting Antivirals Drugs For Hepatitis C Such As Harvoni And Sovaldi Could Cause Liver Failure (1/27/17)
- Is Liver Cancer Associated With Harvoni, Sovaldi, And Other Direct-Acting Antiviral Medications For Hepatitis C? (1/11/17)
Anticoagulants / Bloodthinners:
- Rate Of Gastrointestinal Bleeding Requiring Hospital Readmission Higher With Pradaxa Use Than Warfarin Use (10/4/17)
- New Medical Evidence Suggests Pradaxa And Xarelto May Double The Risk Of Heart Attacks In Atrial Fibrillation Patients (4/12/17)
- Pradaxa Lawsuits And Settlements: Past, Present, And Future Aspects Are Explained In This 2017 Update Report (3/21/17)
- February 2017: Eliquis MDL Established For Federal Court Lawsuits; Placed In Southern District Of New York, With Judge Cote Presiding (2/10/17)
Breast Implants:
- Breast Implant Associated Anaplastic Large-Cell Lymphoma (BIA-ALCL): New Medical Journal Article About Treatments (9/1/17)
- The Association Between Breast Implants And Anaplastic Large Cell Lymphoma (ALCL) Is Better Understood In Recent Years (4/20/17)
- The Rare Lymphoma (Blood Cancer) Linked To Breast Implants Causes Nine Patient Deaths (3/31/17)
Osteoporosis Treatment Drugs:
- Merck Wants The US Supreme Court To Reverse A Federal Appeals Ruling In Fosamax – Femur Fractures Litigation (9/18/17)
- Fosamax – Femur Fracture Lawsuits In Federal Court MDL: March 2017 Appellate Court Ruling Reinstates Lawsuits (3/24/17)
Erectile Dysfunction (ED) Drugs:
- Association Of Melanoma With Viagra, Cialis, Other PDE-5 Drugs: Fall 2017 Review Of Recent Medical Articles (10/31/17)
- August 2017 ED Drugs Label Change Warns That Some Users Of Cialis, Levitra, And Viagra Have Developed NAION Vision Loss (8/24/17)
Heartburn / Acid Reflux Drugs:
- Prilosec / Prevacid / Nexium Federal Court Lawsuits For Kidney Injury Consolidated By MDL Established In August 2017 (8/16/17)
- New "Silent" Side Effect of Prilosec And Nexium: Chronic Kidney Disease (CKD), Without Any Prior Acute Kidney Injury (2/23/17)
Multiple Sclerosis (MS) Treatment Drugs:
- New MS Drug Ocrevus Gets Possible Bad News About Side Effects Soon After Good News About Sales Projections (5/25/17)
- Multiple Sclerosis Drug Tecfidera: FDA Mandates January 2017 Label Change Which Adds Warnings About Liver Injury Cases (2/7/17)
DPP-4 Inhibitors Diabetes Drugs:
Miscellaneous:
- Gadolinium-Containing Contrast Agents Omniscan And Magnevist Being Recalled In The United Kingdom In February 2018 (12/19/17)
- FDA Recommends A Recall For Limbrel "Medical Food" Product But Primus Pharmaceuticals Is Not Complying (12/8/17)
- New Heart Failure Drug Entresto Apparently Has Safety Signal For Hypotension (Low Blood Pressure) Side Effect (11/21/17)
- Gout Medicine Uloric Safety Trial Shows Increased Risk Of Heart-Related Deaths According To November 2017 FDA Alert (11/15/17)
- Viberzi – Pancreatitis Side Effects Can Develop At Any Time While Taking This IBS Drug, According To FDA Safety Warning (10/18/17)
- Will Ocaliva Get Black-Box Warning For Liver Injury Side Effects After September 2017 FDA Report? (9/26/17)
- European Drug Regulator EMA Suspends Use Of MRI Drugs Magnevist, Omniscan, And OptiMARK In July 2017 (8/3/17)
- Keytruda, Opdivo, And Yervoy May Be Associated With Vision Loss And Retinal Detachment In Addition To Uveitis (7/13/17)
- Despite The High Number Of Actemra – Pancreatitis Cases Reported To FDA, No Warning Added To Drug Label (6/26/17)
- There Is Continuing Concern About Whether Victoza Is Associated With Pancreatic Cancer As A Possible Side Effect (6/19/17)
- May 2017 "Dear Doctor" Letter About Aranesp Cases Of Stevens-Johnson Syndrome (SJS) And Toxic Epidermal Necrolysis (TEN) (5/18/17)
- Growing Concern About Reports Of Children Who Developed Neuro-Psychiatric Problems After Taking MiraLAX (5/4/17)
- Iclusig: Leukemia Drug With Many Different Serious Side Effects Had More Warnings Added In November 2016 (1/19/17)
We hope you continue to read Drug Injury Watch and Drug Safety Developments in 2018.
DrugInjuryLaw.com: Medical & Legal Information About Drug Side Effects (All website content by attorney Tom Lamb)
Drug Injury Case Evaluation - Free. Confidential. No Obligation. (Case review done by attorney Tom Lamb)
Leave a Reply